Association of the nutritional risk index recorded prior to allogeneic hematopoietic cell transplantation with the clinical prognosis in children
- PMID: 39866921
- PMCID: PMC11756969
- DOI: 10.1002/jha2.1054
Association of the nutritional risk index recorded prior to allogeneic hematopoietic cell transplantation with the clinical prognosis in children
Abstract
Introduction: The nutritional risk index (NRI), calculated using serum albumin levels and body weight ratio is a known prognostic factor in adult hematopoietic cell transplantation (HCT). However, its usefulness in pediatric HCT settings remains unclear.
Methods: In a retrospective study, we examined pre-transplant NRI impact on outcomes in 82 pediatric patients undergoing allogeneic HCT.
Results: The 2-year non-relapse mortality (NRM) rate was 7.94% (95% confidence interval [CI], 3.05%-19.8%) and 30.8% (95% CI, 16.7%-52.2%) in the high and low NRI groups, respectively (p = 0.0037).
Conclusion: We found that poor nutritional status prior to pediatric HCT led to a worse prognosis, including increased NRM.
Keywords: pediatrics; prognostic factor; stem cell transplantation.
© 2024 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.Transplant Cell Ther. 2022 Dec;28(12):846.e1-846.e9. doi: 10.1016/j.jtct.2022.09.023. Epub 2022 Sep 28. Transplant Cell Ther. 2022. PMID: 36179985 Free PMC article.
-
Pretransplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Nonrelapse Mortality in Allogeneic Hematopoietic Cell Transplantation.Transplant Cell Ther. 2023 Feb;29(2):97.e1-97.e6. doi: 10.1016/j.jtct.2022.11.009. Epub 2022 Nov 11. Transplant Cell Ther. 2023. PMID: 36375798
-
[Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].Zhonghua Xue Ye Xue Za Zhi. 2013 Aug;34(8):659-63. doi: 10.3760/cma.j.issn.0253-2727.2013.08.004. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23978015 Chinese.
-
Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysis.Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e694-e711. doi: 10.1016/j.clml.2020.05.021. Epub 2020 Jun 2. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32616401
-
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis.Transplant Cell Ther. 2021 Oct;27(10):873.e1-873.e13. doi: 10.1016/j.jtct.2021.05.016. Epub 2021 May 28. Transplant Cell Ther. 2021. PMID: 34052505 Free PMC article.
References
-
- Fuji S, Takano K, Mori T, Eto T, Taniguchi S, Ohashi K, et al. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49(12):1505‐1512. - PubMed
-
- Tamaki M, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, et al. Body weight loss before allogeneic hematopoietic stem cell transplantation predicts survival outcomes in acute leukemia patients. Transplant Cell Ther. 2021;27(4):340.e1‐340.el - PubMed
-
- Kerby EH, Li Y, Getz KD, Smith EC, Smith LT, Bunin NJ, et al. Nutritional risk factors predict severe acute graft‐versus‐host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2018;65(2). - PubMed
-
- Sagou K, Ozeki K, Ukai S, Adachi Y, Fukushima N, Kohno A. Impact of a nutritional risk index on clinical outcomes after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019;25(11):2287‐2296. - PubMed
LinkOut - more resources
Full Text Sources